Ductal carcinoma in situ of breast: update 2019.
Badve SS, Gökmen-Polar Y.
Pathology. 2019 Oct;51(6):563-569. doi: 10.1016/j.pathol.2019.07.005. Epub 2019 Aug 28.
Lobular Carcinoma In Situ.
Wen HY, Brogi E.
Surg Pathol Clin. 2018 Mar;11(1):123-145. doi: 10.1016/j.path.2017.09.009. Epub 2017 Dec 8.
Papillary lesions of the breast.
Kulka J, Madaras L, Floris G, Lax SF.
Virchows Arch. 2022 Jan;480(1):65-84. doi: 10.1007/s00428-021-03182-7. Epub 2021 Nov 3.
Overview of breast cancer.
Watkins EJ.
JAAPA. 2019 Oct;32(10):13-17. doi: 10.1097/01.JAA.0000580524.95733.3d.
Lobular Carcinoma In Situ during Preoperative Biopsy and the Rate of Upgrade.
Lee J, Ku GY, Lee H, Park HS, Ku JS, Kim JY, Park S, Park BW.
Cancer Res Treat. 2022 Oct;54(4):1074-1080. doi: 10.4143/crt.2021.864. Epub 2021 Dec 21.
Impact of lobular carcinoma in situ on local recurrence in breast cancer treated with breast conservation therapy: a systematic review and meta-analysis.
Harris CG, Eslick GD.
ANZ J Surg. 2021 Sep;91(9):1696-1703. doi: 10.1111/ans.16671. Epub 2021 Feb 26.
Management of High-Risk Breast Lesions.
Bahl M.
Radiol Clin North Am. 2021 Jan;59(1):29-40. doi: 10.1016/j.rcl.2020.08.005.
Clinical Trials for Ductal Carcinoma In Situ of the Breast.
Han MS, Khan SA.
J Mammary Gland Biol Neoplasia. 2018 Dec;23(4):293-301. doi: 10.1007/s10911-018-9413-3. Epub 2018 Sep 11.
Pre-operative management of Pleomorphic and florid lobular carcinoma in situ of the breast: Report of a large multi-institutional series and review of the literature.
Foschini MP, Miglio R, Fiore R, Baldovini C, Castellano I, Callagy G, Bianchi S, Kaya H, Amendoeira I, Querzoli P, Poli F, Scatena C, Cordoba A, Pietribiasi F, Kovács A, Faistova H, Cserni G, Quinn C.
Eur J Surg Oncol. 2019 Dec;45(12):2279-2286. doi: 10.1016/j.ejso.2019.07.011. Epub 2019 Jul 5.
Imaging and Pathology of Ductal Carcinoma in Situ of the Breast: The Forest and the Trees.
Rahbar H.
Radiology. 2022 May;303(2):285-286. doi: 10.1148/radiol.213292. Epub 2022 Feb 15.
